Prostaglandins in human skin disease.
D015121:6-Ketoprostaglandin F1 alpha / Q000378:metabolism; D015237:Dinoprost; D015232:Dinoprostone; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000378:metabolism; D015230:Prostaglandin D2; D011453:Prostaglandins / Q000378:metabolism*; D011457:Prostaglandins D / Q000378:metabolism; D011458:Prostaglandins E / Q000378:metabolism; D011460:Prostaglandins F / Q000378:metabolism; D011565:Psoriasis / Q000378:metabolism; D012595:Scleroderma, Systemic / Q000378:metabolism; D012867:Skin / Q000378:metabolism; D012871:Skin Diseases / Q000378:metabolism*; D014820:Vitiligo / Q000378:metabolism
D011453:Prostaglandins; D011457:Prostaglandins D; D011458:Prostaglandins E; D011460:Prostaglandins F; D015121:6-Ketoprostaglandin F1 alpha; D015237:Dinoprost; D015232:Dinoprostone; D015230:Prostaglandin D2